Richmond Pharmacology is excited to join the JSCTR Annual Meeting 2026 in Kobe, Japan, on 19–21 February 2026.

Bringing together leaders in clinical research, regulatory science, and trial operations, JSCTR serves as a key platform for advancing high‑quality clinical trials, promoting innovation in study design, and strengthening global collaboration across the clinical research community.

Representing Richmond Pharmacology:

  • Dr Jörg Taubel, Chief Executive Officer
  • Nobuo Ittetsu, Head of Japanese Volunteer Recruitment
  • Minoru Takada, Japanese Business Development Executive

‍

Our Focus at the Conference

  • Innovations in clinical trial methodology
  • Regulatory harmonisation and emerging guidance
  • Best practices in global trial operations
  • Patient‑centric strategies in clinical development
  • Collaboration between academia, industry, and regulatory stakeholders

Connect With Us

If you are attending JSCTR 2026 and would like to explore partnership or development opportunities:

📧 japanbd@richmondpharmacology.com

‍

Learn more here: Japanese Society of Clinical Trials (JSCTR)

‍

Latest news

The Future of Cardiometabolic Research: Five Questions Shaping the Next Decade

October 22, 2026
Cardiometabolic research is continually evolving beyond explanations centred on single causes of disease.
Read more

Upcoming Event

AASLD

05 - 09 November 2026
Richmond Pharmacology is excited to join the AASLD Emerging Topic Conference: Unified Frontiers in Liver Disease in Denver, USA, on 05– 09 November 2026.
View event